These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15200155)

  • 1. A contemporary overview of chronic progressive nephropathy in the laboratory rat, and its significance for human risk assessment.
    Hard GC; Khan KN
    Toxicol Pathol; 2004; 32(2):171-80. PubMed ID: 15200155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of rat chronic progressive nephropathy with human renal disease-implications for human risk assessment.
    Hard GC; Johnson KJ; Cohen SM
    Crit Rev Toxicol; 2009; 39(4):332-46. PubMed ID: 19514917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for the interpretation of renal tubule proliferative lesions occurring in rat kidneys with advanced chronic progressive nephropathy (CPN).
    Hard GC; Seely JC
    Toxicol Pathol; 2005; 33(6):641-9. PubMed ID: 16207638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of advanced chronic progressive nephropathy (CPN) with renal tubule tumors and precursor hyperplasia in control F344 rats from two-year carcinogenicity studies.
    Hard GC; Betz LJ; Seely JC
    Toxicol Pathol; 2012 Apr; 40(3):473-81. PubMed ID: 22298794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-evaluation of the kidney tumors and renal histopathology occurring in a 2-year rat carcinogenicity bioassay of quercetin.
    Hard GC; Seely JC; Betz LJ; Hayashi SM
    Food Chem Toxicol; 2007 Apr; 45(4):600-8. PubMed ID: 17156907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemically exacerbated chronic progressive nephropathy not associated with renal tubular tumor induction in rats: an evaluation based on 60 carcinogenicity studies by the national toxicology program.
    Melnick RL; Burns KM; Ward JM; Huff J
    Toxicol Sci; 2012 Aug; 128(2):346-56. PubMed ID: 22539614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological investigation of diagnostically challenging tubule profiles in advanced chronic progressive nephropathy (CPN) in the fischer 344 RaT.
    Hard GC; Seely JC
    Toxicol Pathol; 2006; 34(7):941-8. PubMed ID: 17178694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemically induced renal tubule tumors in the laboratory rat and mouse: review of the NCI/NTP database and categorization of renal carcinogens based on mechanistic information.
    Lock EA; Hard GC
    Crit Rev Toxicol; 2004; 34(3):211-99. PubMed ID: 15239388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic progressive nephropathy in male F344 rats in 90-day toxicity studies: its occurrence and association with renal tubule tumors in subsequent 2-year bioassays.
    Travlos GS; Hard GC; Betz LJ; Kissling GE
    Toxicol Pathol; 2011 Feb; 39(2):381-9. PubMed ID: 21422264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of the renal effects of ethyl benzene in rodents for assessing human carcinogenic risk.
    Hard GC
    Toxicol Sci; 2002 Sep; 69(1):30-41. PubMed ID: 12215658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consideration of rat chronic progressive nephropathy in regulatory evaluations for carcinogenicity.
    Hard GC; Banton MI; Bretzlaff RS; Dekant W; Fowles JR; Mallett AK; McGregor DB; Roberts KM; Sielken RL; Valdez-Flores C; Cohen SM
    Toxicol Sci; 2013 Apr; 132(2):268-75. PubMed ID: 23104430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of hydroquinone-associated rat renal tumors with spontaneous chronic progressive nephropathy.
    Hard GC; Whysner J; English JC; Zang E; Williams GM
    Toxicol Pathol; 1997; 25(2):132-43. PubMed ID: 9125771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of chronic progressive nephropathy on the incidence of renal tubule cell neoplasms in control male F344 rats.
    Seely JC; Haseman JK; Nyska A; Wolf DC; Everitt JI; Hailey JR
    Toxicol Pathol; 2002; 30(6):681-6. PubMed ID: 12512869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amended final report on the safety assessment of polyacrylamide and acrylamide residues in cosmetics.
    Int J Toxicol; 2005; 24 Suppl 2():21-50. PubMed ID: 16154914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
    J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.